Globant S.A., together with its subsidiaries, provides technology services in the United States, rest of North America, Latin America, Europe, and internationally. The company offers Digital Studio, which integrates artificial intelligence into the software development lifecycle; GUT Studio, which allows clients to better connect brands to end-consumers through experiential marketing; and Enterprise Studio, which leverages tailored technology for streamlined operations and productivity. It also provides AI Industry Studios for the financial services; media, entertainment, sports, and leisure; healthcare and life sciences; CPG, retail, and automotive; gaming and EdTech; airlines; energy, oil, and gas; and high tech and professional services sectors. In addition, the company offers AI Pods, a subscription-based delivery model for AI-powered services; Globant Enterprise AI, an agentic innovation platform; Corporate Hub, which grounds intelligence in how the organization operates; AI Hub, which connects and governs foundation and custom models, enabling industry-specific fine-tuning, continuous evaluation, and optimization; and Agents Hub, which enables autonomous action through the creation and coordination of agents and agentic workflows that operate across systems, teams, and physical environments. Further, it provides GeneXus for enterprise systems evolution; Globant CODA for software development; Navigate Digital Twin for process optimization; Navigate Service Assist for support; and Fusion, for marketing, communications, and advertising, as well as StarMeUp, an employee engagement and talent experience platform; and DaXia, an embedded finance accelerator platform. The company has a collaboration with Pharma Mar, S.A. for cancer drug discovery through artificial intelligence. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg, Luxembourg.
| Business Activity | PASS |
| Debt Ratio (0.36%) | FAIL |
| Cash Ratio (0.17%) | PASS |
| Receivables Ratio (0.00%) | PASS |
| Revenue Ratio (0.00%) | PASS |
| Overall | FAIL |
| Date | EPS Est. | Reported EPS | Surprise % |
|---|---|---|---|
| 2026-08-20 | 1.51 | Pending | -- |
| 2026-05-14 | 1.50 | 1.50 | +0.1% |
| 2026-02-26 | 0.80 | 0.93 | +16.3% |
| 2025-11-13 | 1.55 | 1.53 | -1.1% |
| 2025-08-14 | 1.52 | 1.53 | +0.6% |
| 2025-05-15 | 1.58 | 1.50 | -5.2% |
| 2025-02-20 | 1.74 | 1.75 | +0.8% |
| 2024-11-14 | 1.63 | 1.63 | +0.2% |
| Period | Revenue | Net Income | EBITDA | Gross Profit | Op. Income | EPS |
|---|---|---|---|---|---|---|
| 2026-03-31 | $607.1M | $37.0M | $60.1M | $209.5M | $52.5M | 0.86 |
| 2025-12-31 | $612.5M | $42.0M | $63.0M | $213.7M | $58.6M | 0.94 |
| 2025-09-30 | $617.1M | $34.2M | $58.4M | $214.8M | $63.1M | 0.74 |
| 2025-06-30 | $614.2M | -$2.4M | $6.5M | $217.6M | $58.1M | -0.05 |
| 2025-03-31 | $611.1M | $30.6M | $48.6M | $213.2M | $51.5M | 0.70 |
| 2024-12-31 | — | — | — | — | — | — |
| Holder | Shares | Value | % Held |
|---|---|---|---|
| Brandes Investment Partners L.P. | 3.4M | $137.4M | 0.1% |
| Pzena Investment Management LLC | 3.0M | $119.1M | 0.1% |
| Blackrock Inc. | 2.5M | $101.8M | 0.1% |
| Capital International Investors | 2.2M | $88.4M | 0.1% |
| Alyeska Investment Group, L.p. | 1.7M | $66.4M | 0.0% |
| Shaw D.E. & Co., Inc. | 1.4M | $57.9M | 0.0% |
| ARGA Investment Management, LP | 1.1M | $44.3M | 0.0% |
| Alliancebernstein L.P. | 1.1M | $44.0M | 0.0% |
| Morgan Stanley | 878.1K | $35.2M | 0.0% |
| ClearBridge Investments, LLC | 817.5K | $32.8M | 0.0% |
$2.1B
0.84
1.036
23
$2.5B
$462.7M
+25.0%
2.12
5.35
0.2%
28,773
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| 2026-08-20 | $1.51 | Pending | — |
| 2026-05-14 | $1.50 | $1.50 | +0.1% |
| 2026-02-26 | $0.80 | $0.93 | +16.3% |
| 2025-11-13 | $1.55 | $1.53 | -1.1% |
| 2025-08-14 | $1.52 | $1.53 | +0.6% |
| 2025-05-15 | $1.58 | $1.50 | -5.2% |
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($62.48, 23 analysts) | |||
| 10 | $340.80 | +$284.00 (83%) | 5.6R |
| 50 | $1,704.00 | +$1,420.00 (83%) | 5.6R |
| 100 | $3,408.00 | +$2,840.00 (83%) | 5.6R |
| To Fair Value ($99.91) | |||
| 10 | $340.80 | +$658.30 (193%) | 12.9R |
| 50 | $1,704.00 | +$3,291.50 (193%) | 12.9R |
| 100 | $3,408.00 | +$6,583.00 (193%) | 12.9R |
- Elevated short interest (5.35 days to cover)
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| EPAM | 0.654 |
| ACN | 0.620 |
| CTSH | 0.571 |
| DXC | 0.518 |
| EXLS | 0.501 |
| Ticker | Correlation |
|---|---|
| RENO | -0.246 |
| ED | -0.193 |
| 0762.HK | -0.177 |
| BATS.L | -0.170 |
| NG.L | -0.168 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.